Haichao Wang
30Patents
9h-index
26Co-inventors
75Inventor score
Filing activity: Jan 8, 1997 → May 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6117837A | Inhibiting proinflammatory cytokine production | Human Necessities | 62 | Expired |
| US6303321A | Methods for diagnosing sepsis | Emerging Cross-Sectional Technologies | 57 | Expired |
| US6468533B1 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6448223B1 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6319894A | Complexes and combinations of fetuin with therapeutic agents | Human Necessities | 18 | Expired |
| US7192917B2 | Antagonists of HMG1 for treating inflammatory conditions | Physics | 16 | Expired |
| US7097838B2 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 14 | Expired |
| US7060504B2 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7151082B2 | Antagonists of HMG1 for treating inflammatory conditions | Physics | 10 | Expired |
| US7537908B2 | Methods of diagnosing sepsis by measuring HMG1 | Emerging Cross-Sectional Technologies | 9 | Active |
| US7572446B2 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 8 | Active |
| USD1050550S1 | Tentacle animal bionic lamp | General | 6 | Active |
| US7186555B1 | Prevention of brain damage in stroke | Human Necessities | 4 | Expired |
| US8053206B2 | Antagonists of HMG1 for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 4 | Active |
| US8138141B2 | HMG1 antibody for treating inflammatory conditions | Emerging Cross-Sectional Technologies | 3 | Active |
| US6011005A | Prevention of pregnancy miscarriages | Human Necessities | 2 | Expired |
| US12213475B1 | Insect and fly expelling fan convenient for storage | Human Necessities | 1 | Active |
| US11124558B2 | Use of tetranectin and peptide agonists to treat inflammatory diseases | Human Necessities | 0 | Active |
| US8513227B2 | Inhibition of inflammatory cytokine production with tanshinones | Emerging Cross-Sectional Technologies | 0 | Active |
| US10183971B2 | SAA-domain-specific antibodies and peptide antagonists and use thereof to treat inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US11266716B2 | Use of dermcidin in sterile inflammatory conditions | Human Necessities | 0 | Active |
| US12152196B2 | Continuous solid organic matter pyrolysis polygeneration system and method for using same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11083777B2 | Hemichannel extracellular-domain specific agents for treating ischemia-reperfusion injury | Human Necessities | 0 | Active |
| US11821637B2 | Energy-saving system using electric heat pump to deeply recover flue gas waste heat from heat power plant for district heating | Emerging Cross-Sectional Technologies | 0 | Active |
| US11391475B2 | Radiant air conditioning system for controlling comfortable and healthy indoor environment based on infrared sensing technology | Mechanical Engineering; Lighting; Heating | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.